oninvasive Diagnosis of Giant Cell Arteritis: A Multicenter Trial

Completed

• Conditions: M31.6; Other giant cell arteritis

• Registration Number: DRKS00000594
• Lead Sponsor: niversitätsklinikum Würzburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2011-05-23
• Study Completion: 2012-09-30
• Last Update Posted: 2024-08-19

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Suspicion of temporal arteritis according to clinical criteria of the American College of Rheumatology with clinical indicated biopsie of the temporal artery to confirm diagnosis before steroid treatment.

Exclusion Criteria

Typical MRI exclusion criteria (pace maker, metallic foreign bodies, claustrophobia, allergy against MR contrast material, renal dysfuction with GFR below 30, corticoseroid treatment for more than 14 days

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Assessment of non-invasive imaging in giant cell arteritis (MRI and colour coded duplex sonography)

Secondary Outcome Measures

Name	Time	Method
1. Assessment of the cranial and extracranial involvement.<br>2. Reduce false negative biopsy results due to segmental distriubtion.<br>3. Correlation of imaging findings with clincial and serological parameters.